19 completed, 6 unknown, 5 recruiting, 5 terminated. 11 Not applicable, 11 Phase 2, 10 Phase 1, 1 Early Phase 1, 1 Phase 3.
Follow Prostatic Cancer: new trials by email Literature Review of Prostatic Cancer trials Research Report on Prostatic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contribution of the VERITON-CT Camera in Prostate Bone Radiostereotaxy whole body SPECT/CT - Prostatic Cancer | Not applicable | Not yet recruiting | Centre Henri Becquerel | 30 | 2026-09-15 | 2026-07-24 |
| Dynamic Whole Body PET/ MRI 68Ga-HTK03149 - Prostatic Cancer | Withdrawn | British Columbia Cancer Agency | 2025-08-01 | 2025-01-08 | ||
| Cleaning the Biopsy Needle in TRUS Bx Isopropyl Alcohol, Povidine-iodine, formaldehit - Prostatic Cancer | Phase 2 | Not yet recruiting | Hitit University | 200 | 2025-03-01 | 2025-02-20 |
| Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors VB15010 - Cancer, Neoplasms | Phase 1 / Phase 2 | Recruiting | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 188 | 2024-10-30 | 2025-02-11 |
| High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer High Dose Brachytherapy, Stereostatic Body Radiation Therapy - Prostatic Cancer | Not applicable | Recruiting | University of Nebraska | 53 | 2023-08-29 | 2025-11-05 |
| A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors HS-10502 - Ovarian Cancer, Breast Cancer | Phase 1 | Recruiting | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 318 | 2023-06-09 | 2025-06-05 |
| To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES) Temporary prostatic stent (Exime®), Indwelling catheter - Lower Urinary Tract Symptoms, Prostatic Hyperplasia | Not applicable | Unknown | Lyx Institute | 120 | 2023-06-01 | 2023-05-09 |
| LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology Arrhythmias, Cardiac, Breast Cancer | Recruiting | University of Sydney | 300 | 2023-02-28 | 2026-05-19 | |
| Fusion Versus Cognitive MRI Targeted Prostatic Biopsy MRI fusion targeted prostatic biopsy, MRI cognitive targeted prostatic biopsy - Prostatic Cancer | Not applicable | Completed | Menoufia University | 130 | 2023-01-01 | 2025-01-23 |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NUV-422, Enzalutamide - Prostate Cancer, Prostatic Cancer | Phase 1 / Phase 2 | Withdrawn | Nuvation Bio Inc. | 2022-09-01 | 2022-08-05 | |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| 68Ga-labeled NY108 PET Imaging in Patients 68Ga-labeled NY108 - Prostatic Cancer | Early Phase 1 | Unknown | Affiliated Hospital of Jiangnan University | 100 | 2022-01-04 | 2022-12-01 |
| Safety and Feasibility of Reversible Induction Strategy Patients With Uncertain Difficult Airway, Colon Cancer | Unknown | RenJi Hospital | 20 | 2021-02-01 | 2021-09-14 | |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer 68Ga-PSMA-11 - Prostatic Neoplasm, Prostatic Cancer | Active not recruiting | British Columbia Cancer Agency | 1574 | 2021-02-01 | 2025-05-09 | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NUV-422 - Glioma, Glioma, Malignant | Phase 1 | Terminated | Nuvation Bio Inc. | 74 | 2020-12-08 | 2023-07-14 |
| Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results Retrospectively review of medical data in patients treated by Salvage HIFU for isolated macroscopic recurrence in the prostatic bed after radical prostatectomy and salvage or adjuvant EBRT - Prostatic Cancer | Completed | Hospices Civils de Lyon | 22 | 2020-03-01 | 2020-06-09 | |
| Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy Analgesia Quadratus Lumborum block, Tranversus Abdominis plane block, Bupivacaine - Prostatic Cancer, Pain, Postoperative | Not applicable | Terminated | Jagiellonian University | 12 | 2018-07-31 | 2022-06-06 |
| Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine, ETBX-051; adenoviral brachyury vaccine - Prostatic Neoplasms, Prostatic Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 18 | 2018-07-24 | 2021-05-19 |
| Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer Prostatic Cancer, Prostatic Neoplams | Recruiting | National Cancer Institute (NCI) | 10000 | 2018-02-26 | 2026-10-16 | |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy Prostate bed with integrated boost, Prostate bed irradiation only, Whole Body Bone Scan - Cancer Of Prostate, Prostate Neoplasms | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2018-01-17 | 2026-08-28 |
Showing 20 of 42. Sign in to see all of them.
Prostatic Neoplasms (42) · Breast Neoplasms (6) · Pancreatic Neoplasms (4) · Prostatic Neoplasms, Castration-Resistant (4) · Ovarian Neoplasms (3) · Colorectal Neoplasms (2) · Pain (2) · Prostatic Hyperplasia (2) · Stomach Neoplasms (2) · Arrhythmias, Cardiac (1) · Biliary Tract Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Diabetes Mellitus (1)
Genital Diseases (42) · Genital Diseases, Male (42) · Genital Neoplasms, Male (42) · Male Urogenital Diseases (42) · Neoplasms by Site (42) · Prostatic Diseases (42) · Urogenital Diseases (42) · Urogenital Neoplasms (42) · Neoplasms (41) · Pathological Conditions, Signs and Symptoms (7) · Breast Diseases (6) · Digestive System Diseases (6) · Digestive System Neoplasms (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6)
Radiosurgery (3) · 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (2) · Fluorodeoxyglucose F18 (2) · Midazolam (2) · enzalutamide (2) · 2-Propanol (1) · Androgen Antagonists (1) · Brachytherapy (1) · Bupivacaine (1) · Catheters, Indwelling (1) · Docetaxel (1) · Fentanyl (1) · Ketamine (1) · Mepivacaine (1) · Multiparametric Magnetic Resonance Imaging (1)
National Cancer Institute (NCI) (5) · Nuvation Bio Inc. (3) · Accuray Incorporated (2) · British Columbia Cancer Agency (2) · Affiliated Hospital of Jiangnan University (1) · Alliance Foundation Trials, LLC. (1) · Anders Widmark (1) · Asana BioSciences (1) · Astellas Pharma Inc (1) · AstraZeneca (1) · Centre Henri Becquerel (1) · Cleveland BioLabs (1) · Complexo Hospitalario Universitario de A Coruña (1) · Consorci Sanitari Integral (1) · Dendreon (1)
United States (17) · China (4) · France (3) · Spain (3) · Australia (2) · Canada (2) · Netherlands (2) · South Korea (2) · United Kingdom (2) · Austria (1) · Brazil (1) · Egypt (1) · Italy (1) · Norway (1) · Poland (1)
Peter L Choyke, M.D. (2) · Robert Meier, MD (2) · Anders Widmark, Prof MD (1) · Andrew Stubbs, PhD (1) · Arnaud Dieudonne, PhD (1) · Chunjing Yu (1) · D. Buell, MD (1) · Deborah E Citrin, M.D. (1) · Donald B Fuller, MD (1) · Edwin Posadas, MD (1) · Ester Forastiere, MD (1) · Fabricio B Carrerette (1) · Francois Benard, MD (1) · George Mardirossian, PhD (1) · Gregory Reid, MSc, MBA (1)
PMID 10411052, PMID 11251539, PMID 12187196, PMID 15227649, PMID 15538237, PMID 15867530, PMID 16843240, PMID 16879671, PMID 17936815, PMID 18399830, PMID 18423693, PMID 18480623, PMID 19185977, PMID 19281468, PMID 19836778, PMID 19931979, PMID 19944519, PMID 20141676, PMID 20514284, PMID 20633003, PMID 20643426, PMID 20952022, PMID 21103791, PMID 21108620, PMID 21475707, PMID 22749850, PMID 22749851, PMID 22749852, PMID 22749853, PMID 22763081, PMID 23253772, PMID 23356390, PMID 25129475, PMID 28474112, PMID 28780635, PMID 30191864, PMID 30344644, PMID 30631433, PMID 30638633, PMID 30677455, PMID 32532513, PMID 33568190, PMID 33762322, PMID 35570100, PMID 37129493, PMID 37914976, PMID 38713024, PMID 39996409, PMID 42369177, PMID 7120554